Rima B Shah
Overview
Explore the profile of Rima B Shah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
99
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Singhal S, Shah R, Bansal S, Dutta S
J Family Med Prim Care
. 2024 Dec;
13(11):5198-5206.
PMID: 39723022
Background: Effective communication is a critical and fundamental element of a successful medical practice and exerts a substantial influence on patient contentment, adherence, and disease outcome. This study was planned...
2.
Singhal S, Dutta S, Bansal S, Dutta S, Shah R
Neurol India
. 2024 Oct;
72(5):934-942.
PMID: 39428763
Migraine, a common neurological condition, is characterized by a chronic and recurring headache that affects numerous people globally. Several drugs are available for the treatment and prophylaxis of migraine with...
3.
Dutta S, Shah R, Singhal S, Dutta S, Bansal S, Sinha S, et al.
Drug Des Devel Ther
. 2024 Sep;
18:4029-4031.
PMID: 39268391
No abstract available.
4.
Singhal S, Shah R, Piparva K, Dutta S
J Family Med Prim Care
. 2023 Aug;
12(7):1399-1405.
PMID: 37649754
Background: Package inserts (PIs) serve detailed information on drug products to the users and primary care physicians, so information should be accurate, reliable, and as per the regulatory guidelines. The...
5.
Dutta S, Shah R, Singhal S, Dutta S, Bansal S, Sinha S, et al.
Drug Des Devel Ther
. 2023 Jul;
17:1907-1932.
PMID: 37397787
Metformin has been designated as one of the most crucial first-line therapeutic agents in the management of type 2 diabetes mellitus. Primarily being an antihyperglycemic agent, metformin also has a...
6.
Dutta S, Singhal S, Shah R, Haque M
Crit Rev Oncog
. 2023 May;
27(4):23-37.
PMID: 37199300
Oral cancers (OCs), being one of the frequent malignancies in the head and neck region, need prompt diagnosis and treatment. Apart from basic therapeutic modalities, immunotherapy has now been utilized...
7.
Singh R, Avadhesh A, Sharma G, Dholariya S, Shah R, Goyal B, et al.
Antioxid Redox Signal
. 2022 Oct;
38(10-12):853-876.
PMID: 36242099
Targeted cancer therapy with minimal off-target consequences has shown promise for some cancer types. Although cytochrome P450 (CYP) consists of 18 families, CYP1-4 families play key role in metabolizing xenobiotics...
8.
Shah R, Patel M, Maahs D, Shah V
Int J Pharm Investig
. 2016 Mar;
6(1):1-9.
PMID: 27014614
Many patients with advanced type 2 diabetes mellitus (T2DM) and all patients with T1DM require insulin to keep blood glucose levels in the target range. The most common route of...
9.
Shah R, Gajjar B, Desai S
J Pharmacol Pharmacother
. 2011 Oct;
2(4):248-52.
PMID: 22025852
Objectives: To evaluate appropriateness of prescribing medicines in geriatric patients using both Beers criteria and Phadke's criteria and compare them for validation of Phadke's criteria as a tool to evaluate...